Copyright © 1999 by the European Society of Cardiology.
Editorial
New trials of LMW heparins light and heavy weight as good on short but what about longer distances?
University Hospital, Uppsala, Sweden
References
- Theroux P, Fuster V. Acute coronary syndromes unstable angina and non-Q-wave myocardial infarction. Circulation. 1998;97:11951206
[Free Full Text] - Campbell RWF, Wallentin L, Verheugt FWA. Managment strategies for a better outcome in unstable coronary artery disease. Clin Cardiol. 1998;21:314322[Web of Science][Medline]
- Lancet. 1996;347:561568[CrossRef][Web of Science][Medline]
- Lancet. 1999;354:701707[CrossRef][Web of Science][Medline]
- Hamm CW, Heeschen C, Goldmann B. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med. 1999;340:16231629
[Abstract/Free Full Text] - Oler A, Whooley MA, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA. 1996;276:811815
[Abstract/Free Full Text] - Theroux P, Waters D, Lam J. Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med. 1992;327:141145[Abstract]
- Eur Heart J. 1997;18:14161425
[Abstract/Free Full Text] - Wallentin L. Low molecular weight heparins: a valuable tool in the treatment of acute coronary syndromes. Eur Heart J. 1996;17:14701476
[Abstract/Free Full Text] - Eur Heart J. 1999;20:15531562
[Abstract/Free Full Text] - Cohen M, Demers C, Gurfinkel EP. A comparison of low molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med. 1997;337:447452
[Abstract/Free Full Text] - Klein W, Buchwald A, Hillis SE. Comparison of low molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study. Circulation. 1997;96:6168
[Abstract/Free Full Text] - Antman E, McCabe CH, Premmereur J. Enoxaparin for the acute and chronic management of unstable angina/non-Q-wave myocardial infarction: Results from the TIMI 11B study. Circulation. 1998;98:I-504
- Lindahl B, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol. 1997;29:4348[Abstract]
- Lancet. 1999;354:708715[CrossRef][Web of Science][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||